openPR Logo
Press release

Acute On Chronic Liver Failure (ACLF) Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis

06-17-2025 10:58 AM CET | Health & Medicine

Press release from: The Business Research Company

Acute On Chronic Liver Failure (ACLF)

Acute On Chronic Liver Failure (ACLF)

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Current Acute On Chronic Liver Failure (ACLF) Market Size and Its Estimated Growth Rate?
The market size for acute on chronic liver failure (ACLF) has been experiencing a robust expansion over the past few years. The market, valued at $2.68 billion in 2024, is projected to escalate to $2.89 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.0%. The historical growth can be traced back to factors such as the increasing instances of chronic liver conditions, the augmentation in awareness about maintaining liver health, heightened healTH*Care spending, the introduction of cutting-edge treatment methodologies, the surge in cases of liver damage due to alcohol consumption, the rise in the number of organ transplant operations, advancements in critical healTH*Care, the rapid growth of the older population, and the extensive research conducted on the mechanisms of liver failure.

The market for acute on chronic liver failure (ACLF) is predicted to experience significant growth in the coming years. By 2029, the market is projected to reach $3.89 billion, expanding at a compound annual growth rate (CAGR) of 9.8%. This growth during the forecast period is due to factors such as the rising adoption of liver support devices, breakthroughs in regenerative medicine, an increased emphasis on precision medicine, growing demand for minimally invasive procedures, advancement of targeted therapies, enhancement of healTH*Care infrastructures in emerging markets, an uptick in research and development investments, an increase in metabolic disorder cases, and more public-private partnerships. The forecast period also sees trends like the incorporation of artificial intelligence in diagnosis, creation of bioengineered liver tissues, breakthroughs in extracorporeal liver support devices, application of machine learning in personalized treatment strategies, emergence of gene editing technologies, advancements in liquid biopsy methods, development of specific drug delivery mechanisms, progress in 3D bioprinting for liver regeneration, acceptance of wearable health monitoring devices, and advancements in therapies based on nanotechnology.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21081

How Are Emerging Segments Shaping the Acute On Chronic Liver Failure (ACLF) Market Landscape?
The acute on chronic liver failure (ACLF) market covered in this report is segmented -

1) By Type Of Treatment: Pharmacological, Supportive Care
2) By Mode Of Administration: Oral, Intravenous (IV)
3) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics

Subsegments:
1) By Pharmacological: Antibiotics, Anti-inflammatory Drugs, Vasopressors, Immunomodulators, Antiviral Agents
2) By Supportive Care: Liver Dialysis, Plasma Exchange, Nutritional Support, Mechanical Ventilation, Renal Replacement Therapy (RRT)

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21081&type=smp

Which Growth Factors Are Influencing Acute On Chronic Liver Failure (ACLF) Market Expansion?
The acute on chronic liver failure market is forecasted to expand due to the rising emphasis on precision and personalized medicine. Personalized medicine, which adjusts treatments to individuals' genetic, environmental, and lifestyle factors, has gained traction in improving patient outcomes and enhancing care quality. The increased adoption of this approach can be attributed to advancements in genomics, better availability of biomarker-based diagnostics, improved data analytics technologies, and a growing need for more targeted and effective treatments. Personalized and precision medicine benefit patients with acute-on-chronic liver failure (ACLF) by offering treatment options personalized to their genetic structure, disease severity, and biomarker insights. This leads to outcome improvements and reduces multi-organ failure risks. As an example, Personalized Medicine Coalition (PMC), a nonprofit organization based in the US, reported FDA's approval of 26 new personalized medicines in 2023, a significant jump from the 12 approved in 2022. Thus, the acute on chronic liver failure market is being propelled by this growing interest in precision and personalized medicine.

Who Are the Dominant Players Across Different Acute On Chronic Liver Failure (ACLF) Market Segments?
Major companies operating in the acute on chronic liver failure (ACLF) market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb, AstraZeneca plc, Abbott Laboratories, GSK plc, Eli Lilly and Company, Gilead Sciences Inc, Novo Nordisk A/S, Astellas Pharma Inc., CSL Behring, Grifols S.A., Lupin Pharmaceutical Limited, Ferring Pharmaceuticals, Shire plc, Gyre Therapeutics Inc., Dr. Falk Pharma GmbH, Genfit, eGenesis Inc., Conatus Pharmaceuticals Inc., Cellaion SA, Rheacell GmbH & Co. KG, Martin Pharmaceuticals Inc.

What Are the Latest Developing Trends in the Acute On Chronic Liver Failure (ACLF) Market?
Leading businesses in the acute-on-chronic liver failure (ACLF) market are directing their efforts toward running clinical trials to advance new treatments, regenerative medicine procedures, and specific drug treatments with the intent of enhancing the survival rates of patients. Clinical trials are vital in verifying novel treatment methods, synthetic liver support systems, and immune modulation treatments to boost disease control and lessen death rates. For instance, A-TANGO, funded by the EU horizon, a Spain-based project is scheduled to conduct the "G-TAK trial" in numerous liver centers throughout the UK in September 2024. The trial's goal is to aid critically ill patients affected by alcoholic hepatitis and acute-on-chronic liver failure (ACLF). G-TAK is a combined treatment incorporating a toll-like 4 receptor antagonist (TAK242) that addresses inflammation, and granulocyte colony-stimulating factor (G-CSF, TRL9) which enhances hepatocyte growth and treats acute-on-chronic liver failure (ACLF).

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/acute-on-chronic-liver-failure-aclf-global-market-report

Which Geographic Regions Are Expected to Dominate the Acute On Chronic Liver Failure (ACLF) Market in the Coming Years?
North America was the largest region in the acute on chronic liver failure (ACLF) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute on chronic liver failure (ACLF) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Acute On Chronic Liver Failure (ACLF) Market?
2. What is the CAGR expected in the Acute On Chronic Liver Failure (ACLF) Market?
3. What Are the Key Innovations Transforming the Acute On Chronic Liver Failure (ACLF) Industry?
4. Which Region Is Leading the Acute On Chronic Liver Failure (ACLF) Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute On Chronic Liver Failure (ACLF) Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis here

News-ID: 4069927 • Views:

More Releases from The Business Research Company

Market Trend Insights: The Impact of Emerging Developments on the Insurance Busi …
The insurance business process outsourcing industry is gaining significant traction as companies seek more efficient ways to manage insurance operations. With evolving technologies and a growing number of insurers, this market is set for considerable expansion in the coming years. Let's explore the current market valuation, key players, emerging trends, and segmentation details shaping this sector. Projected Growth and Market Size of the Insurance Business Process Outsourcing Market The insurance
Trends in Growth, Segment Analysis, and Competitive Approaches Influencing the M …
The marine insurance sector is set to undergo significant expansion in the coming years, driven by technological advancements and evolving global risks. This market is adapting to new challenges and opportunities, reflecting shifts in maritime operations and increasing demands for specialized coverage. Here is an in-depth look at the marine insurance market's size, key players, emerging trends, and the main segments fueling its growth. Projected Expansion and Market Size of Marine
Analysis of Key Market Segments Driving the Syndicated Loans Market
The syndicated loans market is poised for substantial expansion in the coming years, driven by a combination of financial trends, investor preferences, and global economic factors. This report explores the projected market size, leading players, notable trends, and segmentation to provide a comprehensive overview of this evolving sector. Expected Market Size and Growth Trajectory of the Syndicated Loans Market The syndicated loans market is anticipated to experience rapid growth, reaching
Market Trend Analysis: The Impact of Emerging Developments on the Remittance Mar …
The digital remittance sector is set for remarkable expansion in the coming years, driven by technological innovations and evolving financial regulations. As cross-border money transfers become more seamless and secure, the industry is positioning itself for impressive growth. Let's explore the projected market size, key players, prevailing trends, and detailed market segments shaping this fast-evolving domain. Forecasted Market Size and Growth of the Digital Remittance Market The digital remittance market

All 5 Releases


More Releases for ACLF

United States Acute On Chronic Liver Failure (ACLF) Market 2025 | Growth Drivers …
Market Size and Growth Global Acute on Chronic Liver Failure market is growing at a CAGR of 6% during the forecast period 2024-2031. Recent Mergers and acquisitions: ✅ In October 2025, Roche completed the acquisition of 89bio for up to USD 3.5 billion to strengthen its portfolio in liver and metabolic diseases. While primarily focused on MASH, the acquisition enhances Roche's long-term capabilities in liver-regeneration therapeutics, potentially extending to ACLF treatment development. ✅
Acute On Chronic Liver Failure (ACLF) Market 2025: Growth, Applications, Innovat …
The Global Acute On Chronic Liver Failure (ACLF) Market is estimated to be valued at USD 4.43 Bn in 2025 and is expected to reach USD 6.44 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.5% from 2025 to 2032. A new report from CoherentMI, titled "Acute On Chronic Liver Failure (ACLF) Market 2025-2032," offers an in-depth examination of the industry, including valuable insights into the Acute
Acute On Chronic Liver Failure (ACLF) Market Forecast 2025-2034: Analysing Major …
Which drivers are expected to have the greatest impact on the over the acute on chronic liver failure (aclf) market's growth? The growing focus on precision and personalized medicine is anticipated to propel the acute-on-chronic liver failure market. Precision and personalized medicine involve tailoring treatments to individuals based on their genetic, environmental, and lifestyle factors to improve outcomes. The rising adoption of personalized medicine is driven by advancements in genomics, biomarker-based
Acute On Chronic Liver Failure (ACLF) Market: Share & Size, Forecasts a CAGR of …
According to a new report published by CoherentMI The Global Acute On Chronic Liver Failure (ACLF) Market is estimated to be valued at USD 4.2 Bn in 2024 and is expected to reach USD 6.1 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.3% from 2024 to 2031. Most recent Report, named "Acute On Chronic Liver Failure (ACLF) Market" Patterns, Offer, Size, Development, Opportunity and Forecast
Acute On Chronic Liver Failure (ACLF) Market Sector Insights, Market Share, and …
The Global Acute On Chronic Liver Failure (ACLF) Market is estimated to be valued at USD 4.2 Bn in 2024 and is expected to reach USD 6.1 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.3% from 2024 to 2031. Latest Report, titled "Acute On Chronic Liver Failure (ACLF) Market" Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by CoherentMI offers a comprehensive analysis of the industry,
Acute On Chronic Liver Failure (ACLF) Market 2024 Size, Global Report till 2031 …
"Acute On Chronic Liver Failure (ACLF) Market 2024," The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Acute On Chronic Liver Failure (ACLF) market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market shares held by major segments within the Acute On